Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca announces positive results from Phase III study of saxagliptin/dapagliflozin combination in patients with type 2 diabetes inadequately controlled on metformin and outlines future development plans for the oral antidiabetic franchise
-
AstraZeneca announces MedImmune’s mavrilimumab and sifalimumab both met primary endpoints in Phase IIb studies
-
AstraZeneca to present respiratory data at ATS 2014 International Conference
-
Amgen and AstraZeneca announce positive results from Phase III study of brodalumab (AMG 827) in patients with moderate-to-severe plaque psoriasis
-
AstraZeneca initiates phase III immunotherapy study for MEDI4736 in patients with lung cancer
-
AstraZeneca issues update on strategy to deliver value to shareholders
-
US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia
-
AstraZeneca Board rejects Pfizer proposal
-
Statement regarding Pfizer announcement
-
Statement regarding Pfizer announcement
Latest articles and press releases
All of our latest press releases and articles are available to explore
